What is StoneBriar Pharmacy?
Established in 2012, StoneBriar Pharmacy operates as a PCAB-accredited compounding pharmacy, distinguishing itself through highly personalized medication solutions. The company serves a diverse patient base with specialized offerings in hormone replacement therapy, veterinary compounds, and complex medication therapy management. Their market position is anchored in a commitment to precision medicine, addressing critical health needs in dermatology, addiction management, and oncology. By integrating traditional pharmacy services with advanced compounding techniques, StoneBriar Pharmacy maintains a competitive edge in the personalized healthcare landscape, ensuring that patient-specific requirements are met with rigorous quality standards.
How much funding has StoneBriar Pharmacy raised?
StoneBriar Pharmacy has raised a total of $30K across 1 funding round:
Debt
$30K
Debt (2021): $30K with participation from PPP
Key Investors in StoneBriar Pharmacy
PPP
Public-Private Partnership
What's next for StoneBriar Pharmacy?
With the recent influx of capital, StoneBriar Pharmacy is poised to accelerate its strategic initiatives, focusing on operational scaling and the expansion of its clinical service offerings. The firm is expected to prioritize investments in advanced compounding technology and infrastructure to support its growing patient volume. Furthermore, the company will likely leverage this financial backing to strengthen its market presence in the competitive compounding sector, potentially exploring new therapeutic areas or enhancing its digital health integration. As the pharmacy transitions through this growth phase, the focus remains on maintaining its accreditation standards while scaling its footprint to meet the rising demand for customized pharmaceutical care.
See full StoneBriar Pharmacy company page
